Concepedia

Marianna Zavodovskaya

MZ

Statistics

Publications

13

Citations

476

H-Index

11

Active since

2005

Affiliations

Gilead Sciences (United States)(Current)

University of California, San Francisco

Weill Cornell Medicine

Cornell University

Osaka International Cancer Institute

Marianna Zavodovskaya is an author at Gilead Sciences (United States) specializing in pharmacology, medicine, and oncology.

ORCID

Publications per year

2005–2025

13

Publications

13

Nordihydroguaiaretic Acid (NDGA) Inhibits the IGF-1 and c-erbB2/HER2/neu Receptors and Suppresses Growth in Breast Cancer Cells

Jack Youngren, Karissa Gable, Cristina Peñaranda et al. · Breast Cancer Research and Treatment · 2005 · 113 citations

, , +16

Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth

Karissa Gable, Betty A. Maddux, Cristina Peñaranda et al. · Molecular Cancer Therapeutics · 2006 · 68 citations

, , +11

Inhibition of IGF-1R and lipoxygenase by nordihydroguaiaretic acid (NDGA) analogs

Joseph Blecha, Marc O. Anderson, Jennifer M. Chow et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 55 citations · Full text

, , +7

Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF‐1 receptor tyrosine kinases, blocks the growth of HER2‐overexpressing human breast cancer cells

Marianna Zavodovskaya, Michael J. Campbell, Betty A. Maddux et al. · Journal of Cellular Biochemistry · 2007 · 49 citations

, , +17

Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival

Manish A. Shah, David Cunningham, Jean‐Philippe Metges et al. · Journal for ImmunoTherapy of Cancer · 2021 · 43 citations · Full text

, , +17

1–5 of 13